A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty. A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Parti ...
A Phase III, Open-label, Multicentre, Single Arm Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Chinese Paediatric Participants With Central Precocious Puberty. A Phase III, Open-label, Multicentre, Single Arm Study to Assess the Efficacy and Safety of the Trip ...
Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty. Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precoc ...
An Open-label, Multicentre, Single Arm Study to Assess the Efficacy and Safety of Triptorelin 3-month Formulation in Chinese Children With Central Precocious Puberty An Open-label, Multicentre, Single Arm Study to Assess the Efficacy and Safety of Triptorelin 3-mont ...
Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Cent ...
An Open-label, Non-comparative, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Triptorelin Pamoate (Embonate) 22.5 mg 6-month Formulation in Patients Suffering From Central (Gonadotropin-dependent) Precocious Puberty An Open-label, Non-comparative, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of T ...
Triptorelin 6-month formulation for children who mature too early because of a brain hormone
An open-label, non-comparative, multicenter study on the efficacy, safety, and pharmacokinetics of triptorelin pamoate (embonate) 22.5 mg 6-month formulation in patients suffering from central (gonadotropin-dependent) precocious puberty - Triptorelin 6-month Formulation in Patients With Central Precocious Puberty An open-label, non-comparative, multicenter study on the efficacy, safety, and pharmacokinetics of t ...
Central Precocious Puberty MedDRA version: 18.0;Level: PT;Classification code 10058084;Term: Precocious puberty;System Organ Class: 10014698 - Endocrine disorders;Therapeutic area: Body processes [G] - Biological Phenomena [G16] Central Precocious Puberty MedDRA version: 18.0;Level: PT;Classification code 10058084;Term: Precoci ...